Results 171 to 180 of about 6,825,486 (291)
Generating geochemical and mineralogy distributions of soil in the conterminous United States using Bayesian hierarchical spatial models. [PDF]
Bondo KJ, Wolf TM, Walter WD.
europepmc +1 more source
Estimating Parameters of the Three-Parameter Lognormal Distribution
Rodrigo Aristizabal
semanticscholar +1 more source
ABSTRACT Purpose Endogenous renal chemical exchange saturation transfer (CEST) imaging enables contrast‐agent‐free assessment of renal metabolism but is highly sensitive to respiratory motion. Existing approaches, such as timed breathing, require high patient compliance or preclinical mechanical ventilation, limiting clinical translation.
Patrik Jan Gallinnis +12 more
wiley +1 more source
Performance analysis over q-Weibull fading channels for symbol error probability evaluation using a tighter Gaussian Q approximation. [PDF]
Samal S +5 more
europepmc +1 more source
ABSTRACT This study examines whether public data availability improves corporate ESG performance. Exploiting the rollout of China's data‐sharing platforms as a quasi‐natural experiment, we find that platform adoption significantly enhances firms' ESG outcomes. Treated firms exhibit lower toxic emissions, higher labor income shares and charitable giving,
Lixing Deng +3 more
wiley +1 more source
A susceptible cluster in a religious camp allowed 2018-2019 measles outbreak in Japan: resurgence of a formerly eliminated virus. [PDF]
Kobayashi T, Nishiura H.
europepmc +1 more source
Abstract Background MR‐US guided biopsies support biologic correlation in HDR prostate brachytherapy, but steep dose gradients and millimeter‐scale localization uncertainty limit the validity of nominal biopsy doses. Purpose To assess how localization uncertainty affects the robustness of biopsy DVH dose thresholds in HDR prostate brachytherapy and to ...
Matthew Muscat +4 more
wiley +1 more source
Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023. [PDF]
Mogasale VV +9 more
europepmc +1 more source
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis
In patients with systemic lupus erythematosus (SLE), increased type I interferon signaling is associated with increased disease activity across organs, including in the kidney, which can cause lupus nephritis (LN). Anifrolumab, which abrogates type I interferon signaling, is an approved treatment for moderate to severe SLE.
Joachim Almquist +6 more
wiley +1 more source

